Areej was working together with Dr JL Caplin, Dr IN Savina, Dr D Berillo and Professor AB Cundy on the development of novel approach for the phenol degradation.
Welcoming news of the double win, Professor David Timson, Head of the School of Pharmacy and Biomolecular Science said: “This is a fantastic achievement and important recognition of the important research being undertaken by Dr Raveendran and Dr Berillo here in Brighton. Their work is helping to push the boundaries of knowledge in their field and could lead to the development of important practical medical applications that could revolutionise treatments and bring major benefit to patients.”
Marie Skłodowska-Curie Research Fellowships enable experienced researchers to work in academic institutions around the world and help to promote collaboration between academics and industry.
Dr Sreejith Raveendran is a Marie Skłodowska-Curie Fellow who will join the group in October to work on the developing novel nanoparticle based formulations for cancer treatment.
Dr Raveendran graduated with his PhD in Bionanoscience with an emphasis on cancer drug delivery and nanomedicine from Toyo University, Japan in 2013. After acquiring his doctoral degree from Bio Nano Electronics Research centre, he is pursuing his nanoresearch in cancer nanotechnology and targeted nanotherapy through the postdoctoral research position.